Advanced stoichiometric analysis of metabolic networks of mammalian Systems

Critical Reviews in Biomedical Engineering

Volumn 39, Issue 6, 2011, Pages 511-534

  Orman, Mehmet A ^a   Berthiaume, Francois ^a   Androulakis, Ioannis P ^a   Ierapetritou, Marianthi G ^a  

^a The State University of New Jersey   (United States)

Author keywords

Flux balance analysis; Mammalian cells; Metabolic flux analysis; Metabolic pathway analysis

Indexed keywords

BIOLOGY; CELL ENGINEERING; CELLS; COMPLEX NETWORKS; CYTOLOGY; MAMMALS; METABOLISM; PROTEINS;

ENGINEERING PRINCIPLES; FLUX BALANCE ANALYSIS; MAMMALIAN CELLS; METABOLIC CONDITIONS; METABOLIC FLUX ANALYSIS; METABOLIC PATHWAY ANALYSIS; REGULATORY MECHANISM; TOXICOLOGICAL EFFECTS;

METABOLIC ENGINEERING;

HUMAN; MAMMAL; MAMMAL CELL; METABOLIC DISORDER; METABOLIC ENGINEERING; METABOLISM; NONHUMAN; PRIORITY JOURNAL; REVIEW; STOICHIOMETRY;

MAMMALIA;

EID: 84555208596     PISSN: 0278940X     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevBiomedEng.v39.i6.30     Document Type: Review

References (154)

1. Martens DE. Metabolic flux analysis of mammalian cells. In: Al-Rubeai M, Fussenegger M, editors. Systems biology. Amsterdam: Springer; 2007. p. 275-99.
2. Yarmush ML, Berthiaume F. Metab Eng and human disease. Nat Biotech. 1997;15(6): 525-8.
3. Terzer M, Maynard ND, Covert MW, Stelling J. Genome-scale metabolic networks. Wiley Interdisciplinary Reviews: Systems Biology and Medicine. 2009;1(3):285-97.
4. Niklas J, Schneider K, Heinzle E. Metabolic flux analysis in eukaryotes. Curr Opin Biotechnol. 2010;21(1):63-9.
5. Quek L-E, Dietmair S, Krömer JO, Nielsen LK. Metabolic flux analysis in mammalian cell culture. Metab Eng. 2010;12(2):161-71.
6. Dauner M. From fluxes and isotope labeling patterns towards in silico cells. Curr Opin Biotechnol. 2010;21(1):55-62.
7. Wiechert W. 13C metabolic flux analysis. Metab Eng. 2001;3(3):195-206.
8. Zamboni N. 13C metabolic flux analysis in complex systems. Current Opinion in Biotechnology. 2011;22(1):103-8.
9. Raman K, Chandra N. Flux balance analysis of biological systems: applications and challenges. Brief Bioinform. 2009;10(4):435-49.
10. Kauffman KJ, Prakash P, Edwards JS. Advances in flux balance analysis. Curr Opin Biotechnol. 2003;14(5):491-6.
11. Klamt S, Stelling J. Two approaches for metabolic pathway analysis? Trends Biotechnol. 2003;21(2):64-9.
12. Trinh CT, Wlaschin A, Srienc F. Elementary mode analysis: a useful metabolic pathway analysis tool for characterizing cellular metabolism. Appl Microbiol Biotechnol. 2009;81(5):813-26.
13. Orman MA, Berthiaume F, Androulakis IP, Ierapetritou MG. Pathway analysis of liver metabolism under stressed condition. J Theoret Biol. 2011;272(1):131-40.
14. Arai K, Lee K, Berthiaume F, Tompkins RG, Yarmush ML. Intrahepatic amino acid and glucose metabolism in a D-galactosamine-induced rat liver failure model. Hepatology. 2001;34(2):360-71.
15. Chan C, Berthiaume F, Lee K, Yarmush ML. Metabolic flux analysis of hepatocyte function in hormone-and amino acid-supplemented plasma. Metab Eng. 2003;5(1):1-15.
16. Lee K, Berthiaume F, Stephanopoulos GN, Yarmush DM, Yarmush ML. Metabolic flux analysis of postburn hepatic hypermetabolism. Metab Eng. 2000;2(4):312-27.
17. Lee K, Berthiaume F, Stephanopoulos GN, Yarmush ML. Profiling of dynamic changes in hypermetabolic livers. Biotechnol Bioeng. 2003;83(4):400-15.
18. Banta S, Vemula M, Yokoyama T, Jayaraman A, Berthiaume F, Yarmush ML. Contribution of gene expression to metabolic fluxes in hypermetabolic livers induced through burn injury and cecal ligation and puncture in rats. Biotechnol Bioeng. 2007;97(1):118-37.
19. Banta S, Yokoyama T, Berthiaume F, Yarmush ML. Effects of dehydroepiandrosterone administration on rat hepatic metabolism following thermal injury. J Surg Res. 2005;127(2):93-105.
20. Çalik P, Akbay A. Mass flux balance-based model and metabolic flux analysis for collagen synthesis in the fibrogenesis process of human liver. Med Hypoth. 2000;55(1):5-14.
21. Chan C, Berthiaume F, Lee K, Yarmush ML. Metabolic flux analysis of cultured hepatocytes exposed to plasma. Biotechnol Bioeng. 2003;81(1):33-49.
22. Chan C, Hwang D, Stephanopoulos GN, Yarmush ML, Stephanopoulos G. Application of multivariate analysis to optimize function of cultured hepatocytes. Biotechnol Prog. 2003;19(2):580-98.
23. Iyer VV, Yang H, Ierapetritou MG, Roth CM. Effects of glucose and insulin on HepG2-C3A cell metabolism. Biotechnol Bioeng. 2010;107(2):347-356.
24. Orman MA, Arai K, Yarmush ML, Androulakis IP, Berthiaume F, Ierapetritou MG. Metabolic flux determination in perfused livers by mass balance analysis: effect of fasting. Biotechnol Bioeng. 2010;107(5):825-35.
25. Yang H, Ierapetritou MG, Roth CM. Effects of amino acid transport limitations on cultured hepatocytes. Biophys Chem. 2010;152(1-3):89-98.
26. Yang H, Roth CM, Ierapetritou MG. A rational design approach for amino acid supplementation in hepatocyte culture. Biotechnol Bioeng. 2009;103(6):1176-91.
27. Yokoyama T, Banta S, Berthiaume F, Nagrath D, Tompkins RG, Yarmush ML. Evolution of intrahepatic carbon, nitrogen, and energy metabolism in a D-galactosamine-induced rat liver failure model. Metab Eng. 2005;7(2):88-103.
28. Izamis M-L, Sharma NS, Uygun B, Bieganski R, Saeidi N, Nahmias Y, et al. In situ metabolic flux analysis to quantify the liver metabolic response to experimental burn injury. Biotechnol Bioeng. 2011;108(4):839-52.
29. Kantor PF, Lucien A, Kozak R, Lopaschuk GD. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circ Res. 2000;86(5):580-8.
30. Chance EM, Seeholzer SH, Kobayashi K, Williamson JR. Mathematical analysis of isotope labeling in the citric acid cycle with applications to 13C NMR studies in perfused rat hearts. J Biol Chem. 1983;258(22):13785-94.
31. Chatham JC, Seymour A-ML. Cardiac carbohydrate metabolism in Zucker diabetic fatty rats. Cardiovasc Res. 2002;55(1):104-12.
32. Lauzier B, Vaillant F, Gélinas R, Bouchard B, Brownsey R, Thorin E, et al. Ivabradine reduces heart rate while preserving metabolic fluxes and energy status of healthy normoxic working hearts. Am J Physiol: Heart Circ Physiol. 2011;300(3):H845-H852.
33. Obrzut S, Tiongson J, Jamshidi N, Phan H, Hoh C, Birgersdotter-Green U. Assessment of metabolic phenotypes in patients with non-ischemic dilated cardiomyopathy undergoing cardiac resynchronization therapy. J Cardiovasc Transl Res. 2010;3(6):643-51.
34. Chatham JC, Forder JR, Glickson JD, Chance EM. Calculation of absolute metabolic flux and the elucidation of the pathways of glutamate labeling in perfused rat heart by C NMR spectroscopy and nonlinear least squares analysis. J Biol Chem. 1995;270(14):7999-8008.
35. Des Rosiers C, Lloyd S, Comte B, Chatham JC. A critical perspective of the use of 13C-isotopomer analysis by GCMS and NMR as applied to cardiac metabolism. Metab Eng. 2004;6(1):44-58.
36. Cohen DM, Bergman RN. Estimation of metabolic flux from dominant rate constants in vivo: application to brain and heart. Metab Eng. 2004;6(1):59-74.
37. Li W, Bian F, Chaudhuri P, Mao X, Brunengraber H, Yu X. Delineation of substrate selection and anaplerosis in tricarboxylic acid cycle of the heart by 13C NMR spectroscopy and mass spectrometry. NMR Biomed. 2011;24(2):176-87.
38. Williams H, King N, Griffiths EJ, Suleiman MS. Glutamate-loading stimulates metabolic flux and improves cell recovery following chemical hypoxia in isolated cardiomyocyte. J Mol Cell Cardiol. 2001;33(12):2109-19.
39. Yu X, White LT, Doumen C, Damico LA, LaNoue KF, Alpert NM, et al. Kinetic analysis of dynamic 13C NMR spectra: metabolic flux, regulation, and compartmentation in hearts. Biophys J. 1995;69(5):2090-102.
40. Zhou L, Salem JE, Saidel GM, Stanley WC, Cabrera ME. Mechanistic model of cardiac energy metabolism predicts localization of glycolysis to cytosolic subdomain during ischemia. Am J Physiol: Heart Circ Physiol. 2005;288(5):H2400-H2411.
41. Sidorenko Y, Wahl A, Dauner M, Genzel Y, Reichl U. Comparison of metabolic flux distributions for MDCK cell growth in glutamine-and pyruvate-containing media. Biotechnol Prog. 2008;24(2):311-20.
42. Wahl A, Sidorenko Y, Genzel Y, Reichl U. Metabolic flux distributions of adherently growing MDCK cells in different media, in cells and culture. Noll T, editor. Amsterdam: Springer; 2010. p. 459-62.
43. Altamirano C, Illanes A, Casablancas A, Gámez X, Cairó JJ, Gòdia C. Analysis of CHO cells metabolic redistribution in a glutamate-based defined medium in continuous culture. Biotechnol Prog. 2001;17(6):1032-41.
44. Nyberg GB, Balcarcel RR, Follstad BD, Stephanopoulos G, Wang DIC. Metabolism of peptide amino acids by Chinese hamster ovary cells grown in a complex medium. Biotechnol Bioeng. 1999;62(3):324-35.
45. Provost A, Bastin G. Dynamic metabolic modelling under the balanced growth condition. J Process Control. 2004;14(7):717-28.
46. Sengupta N, Rose ST, Morgan JA. Metabolic flux analysis of CHO cell metabolism in the late non-growth phase. Biotechnol Bioeng. 2011;108(1):82-92.
47. Goudar C, Biener R, Boisart C, Heidemann R, Piret J, de Graaf A, et al. Metabolic flux analysis of CHO cells in perfusion culture by metabolite balancing and 2D [13C, 1H] COSY NMR spectroscopy. Metab Eng. 2010;12(2):138-49.
48. Balcarcel RR, Clark LM. Metabolic screening of mammalian cell cultures using well-plates. Biotechnol Prog. 2003;19(1):98-108.
49. Bonarius HPJ, Houtman JHM, Schmid G, de Gooijer CD, Tramper J. Metabolic-flux analysis of hybridoma cells under oxidative and reductive stress using mass balances. Cytotechnology. 2000;32(2):97-107.
50. Bonarius HPJ, Özemre A, Timmerarends B, Skrabal P, Tramper J, Schmid G, et al. Metabolic-flux analysis of continuously cultured hybridoma cells using 13CO2 mass spectrometry in combination with 13C-lactate nuclear magnetic resonance spectroscopy and metabolite balancing. Biotechnol Bioeng. 2001;74(6):528-38.
51. Europa AF, Gambhir A, Fu P-C, Hu W-S. Multiple steady states with distinct cellular metabolism in continuous culture of mammalian cells. Biotechnol Bioeng. 2000;67(1):25-34.
52. Follstad BD, Balcarcel RR, Stephanopoulos G, Wang DIC. Metabolic flux analysis of hybridoma continuous culture steady state multiplicity. Biotechnol Bioeng. 1999;63(6):675-83.
53. Gambhir A, Korke R, Lee J, Fu P-C, Europa A, Hu W-S. Analysis of cellular metabolism of hybridoma cells at distinct physiological states. J Biosci Bioeng. 2003;95(4):317-27.
54. Vriezen N, Romein B, Luyben KCAM, van Dijken JP. Effects of glutamine supply on growth and metabolism of mammalian cells in chemostat culture. Biotechnol Bioeng. 1997;54(3):272-86.
55. Xie L, Wang DIC. Applications of improved stoichiometric model in medium design and fed-batch cultivation of animal cells in bioreactor. Cytotechnology. 1994;15(1):17-29.
56. Xie L, Wang DIC. Stoichiometric analysis of animal cell growth and its application in medium design. Biotechnol Bioeng. 1994;43(11):1164-74.
57. Xie L, Wang DIC. Energy metabolism and ATP balance in animal cell cultivation using a stoichiometrically based reaction network. Biotechnol Bioeng. 1996;52(5):591-601.
58. Xie L, Wang DIC. Material balance studies on animal cell metabolism using a stoichiometrically based reaction network. Biotechnol Bioeng. 1996;52(5):579-90.
59. Xie LZ, Wang DIC. Fed-batch cultivation of animal-cells using different medium design concepts and feeding strategies. Biotechnol Bioeng. 1994;43(11):1175-89.
60. Xie LZ, Wang DIC. High cell density and high monoclonal antibody production through medium design and rational control in a bioreactor. Biotechnol Bioeng. 1996;51(6):725-9.
61. Portais J-C, Schuster R, Merle M, Canioni P. Metabolic flux determination in C6 glioma cells using carbon-13 distribution upon [1-13C]glucose incubation. Eur J Biochem. 1993;217(1):457-68.
62. Sepúlveda DE, Andrews BA, Papoutsakis ET, Asenjo JA. Metabolic flux analysis of embryonic stem cells using three distinct differentiation protocols and comparison to gene expression patterns. Biotechnol Prog. 2010;26(5):1222-9.
63. Banta S, Yokoyama T, Berthiaume F, Yarmush ML. Quantitative effects of thermal injury and insulin on the metabolism of the skeletal muscle using the perfused rat hindquarter preparation. Biotechnol Bioeng. 2004;88(5):613-29.
64. Apweiler R, Bairoch A, Wu CH, Barker WC, Boeckmann B, Ferro S, et al. UniProt: the Universal Protein knowledgebase. Nucleic Acids Res. 2004;32(suppl 1):D115-D119.
65. Schomburg I, Chang A, Schomburg D. BRENDA, enzyme data and metabolic information. Nucleic Acids Res. 2002;30(1):47-4.
66. Karp PD, Ouzounis CA, Moore-Kochlacs C, Goldovsky L, Kaipa P, Ahrén D, et al. Expansion of the BioCyc collection of pathway/genome databases to 160 genomes. Nucleic Acids Res. YEAR 33(19):6083-9.
67. Kanehisa M S Goto. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 2000;28(1):27-30.
68. Bairoch A. The ENZYME database in 2000. Nucleic Acids Res. 2000;28(1):304-5.
69. Duarte N, Becker S, Jamshidi N, Thiele I, Mo M, Vo T, et al. Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc Natl Acad Sci USA. 2007;104:1777-82.
70. Ma H, Sorokin A, Mazein A, Selkov A, Selkov E, Demin O, et al. The Edinburgh human metabolic network reconstruction and its functional analysis. Mol Syst Biol. 2007;3:135.
71. Hao T, Ma H, Zhao X, Goryanin I. Compartmentalization of the Edinburgh Human Metabolic Network. BMC Bioinformatics. 2010;11:393.
72. Romero P, Wagg J, Green M, Kaiser D, Krummenacker M, Karp P. Computational prediction of human metabolic pathways from the complete human genome. Genome Biol. 2005;6:R2.
73. Shlomi T, Cabili M, Herrgard M, Palsson B, Ruppin E. Network-based prediction of human tissue-specific metabolism. Nat Biotechnol. 2008;26:1003-10.
74. Shlomi T, Cabili M, Ruppin E. Predicting metabolic biomarkers of human inborn errors of metabolism. Mol Syst Biol. 2009;5:263.
75. Jerby L, Shlomi T, Ruppin E. Computational reconstruction of tissue-specific metabolic models: application to human liver metabolism. Mol Syst Biol. 2010;6:401.
76. Gille C, Bolling C, Hoppe A, Bulik S, Hoffmann S, Hubner K, et al. HepatoNet1: a comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver physiology. Mol Syst Biol. 2010;6:411.
77. Seo S, Lewin H. Reconstruction of metabolic pathways for the cattle genome. BMC Syst Biol. 2009;3:33.
78. Evsikov A, Dolan M, Genrich M, Patek E, Bult C. MouseCyc: a curated biochemical pathways database for the laboratory mouse. Genome Biol. 2009;10:R84.
79. Quek L, Nielsen L. On the reconstruction of the Mus musculus genome-scale metabolic network model. Genome Inform. 2008;21:89-100.
80. Selvarasu S, Karimi IA, Ghim G-H, Lee D-Y. Genome-scale modeling and in silico analysis of mouse cell metabolic network. Mol BioSyst. 2009;6(1):152-61.
81. Sheikh K, Forster J, Nielsen L. Modeling hybridoma cell metabolism using a generic genome-scale metabolic model of Mus musculus. Biotechnol Prog. 2005;21:112-21.
82. Selvarasu S, Karimi I, Ghim G, Lee D. Genome-scale modeling and in silico analysis of mouse cell metabolic network. Mol Biosyst. 2010;6:152-61.
83. Sigurdsson M, Jamshidi N, Steingrimsson E, Thiele I, Palsson B. A detailed genome-wide reconstruction of mouse metabolism based on human Recon 1. BMC Sys Biol. 2010;4(1):140.
84. Henry O, Kamen A, Perrier M. Monitoring the physiological state of mammalian cell perfusion processes by on-line estimation of intracellular fluxes. J Process Control. 2007;17(3):241-51.
85. Izamis ML, Sharma NS, Uygun B, Bieganski R, Saeidi N, Nahmias Y, et al. In situ metabolic flux analysis to quantify the liver metabolic response to experimental burn injury. Biotechnology and Bioengineering. 2011;108(4):839-52.
86. Nadeau I, Jacob D, Perrier M, Kamen A. 293SF Metabolic flux analysis during cell growth and infection with an adenoviral vector. Biotechnol Prog. 2000;16(5):872-84.
87. Niklas J, Noor F, Heinzle E. Effects of drugs in subtoxic concentrations on the metabolic fluxes in human hepatoma cell line Hep G2. Toxicol Appl Pharmacol. 2009;240(3):327-36.
88. Omasa T, Furuichi K, Iemura T, Katakura Y, Kishimoto M, Suga K-i. Enhanced antibody production following intermediate addition based on flux analysis in mammalian cell continuous culture. Bioproc Biosyst Eng. 2010;33(1):117-25.
89. Varma A, Palsson BO. Metabolic flux balancing-basic concepts, scientific and practical use. Bio-Technology. 1994;12(10):994-8.
90. Christensen B, Nielsen J. Metabolic network analysis. In: Sonnleitner B, editor. Bioanalysis and biosensors for bioprocess monitoring. Berlin/Heidelberg: Springer; 2000. p. 209-31.
91. Antoniewicz MR, Kelleher JK, Stephanopoulos G. Elementary metabolite units (EMU): a novel framework for modeling isotopic distributions. Metab Eng. 2007;9(1):68-86.
92. Bonarius HPJ, Timmerarends B, de Gooijer CD, Tramper J. Metabolite-balancing techniques vs. 13C tracer experiments to determine metabolic fluxes in hybridoma cells. Biotechnol Bioeng. 1998;58(2-3):258-62.
93. Maier K, Hofmann U, Bauer A, Niebel A, Vacun G, Reuss M, et al. Quantification of statin effects on hepatic cholesterol synthesis by transient 13C-flux analysis. Metab Eng. 2009;11(4-5):292-309.
94. Maier K, Hofmann U, Reuss M, Mauch K. Identification of metabolic fluxes in hepatic cells from transient 13C-labeling experiments: Part II. Flux estimation. Biotechnol Bioeng. 2008;100(2):355-70.
95. Metallo CM, Walther JL, Stephanopoulos G. Evaluation of 13C isotopic tracers for metabolic flux analysis in mammalian cells. J Biotechnol. 2009;144(3):167-74.
96. Santos SS, Leite SB, Sonnewald U, Carrondo MJT, Alves PM. Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nat Biotech. 2008;26(10):1179-86.
97. Santos SS, Leite SB, Sonnewald U, Carrondo MJT, Alves PM. Stirred vessel cultures of rat brain cells aggregates: characterization of major metabolic pathways and cell population dynamics. J Neurosci Res. 2007;85(15):3386-97.
98. Wiechert W, Möllney M, Petersen S, de Graaf AA. A Universal Framework for 13C Metabolic Flux Analysis. Metabolic Engineering. 2001;3(3):265-83.
99. Hiller K, Metallo CM, Kelleher JK, Stephanopoulos G. Nontargeted elucidation of metabolic pathways using stable-isotope tracers and mass spectrometry. Analytl Chem. 2010;82(15):6621-8.
100. Weitzel M, Wiechert W, Noh K. The topology of metabolic isotope labeling networks. BMC Bioinformatics. 2007;8(1):315.
101. Covert MW, Palsson BO. Transcriptional regulation in constraints-based metabolic models of Escherichia coli. J Biol Chem. 2002;277(31):28058-64.
102. Covert MW, Schilling CH, Palsson BO. Regulation of gene expression in flux balance models of metabolism. J Theoret Biol. 2001;213(1):73-88.
103. Beard DA, Qian H. Thermodynamic-based computational profiling of cellular regulatory control in hepatocyte metabolism. Am J Physiol: Endocrin Metab. 2005;288(3):E633-E644.
104. Nolan RP, Fenley AP, Lee K. Identification of distributed metabolic objectives in the hypermetabolic liver by flux and energy balance analysis. Metab Eng. 2006;8(1):30-45.
105. Ibarra RU, Edwards JS, Palsson BO. Escherichia coli K-12 undergoes adaptive evolution to achieve in silico predicted optimal growth. Nature. 2002;420(6912):186-9.
106. Ramakrishna R, Edwards JS, McCulloch A, Palsson BO. Flux-balance analysis of mitochondrial energy metabolism: consequences of systemic stoichiometric constraints. Am J Physiol: Regul Integr Comp Physiol. 2001;280(3):R695-R704.
107. Iyer VV, Ovacik MA, Androulakis IP, Roth CM, Ierapetritou MG. Transcriptional and metabolic flux profiling of triadimefon effects on cultured hepatocytes. Toxicol Appl Pharmacol. 2010;248(3):165-77.
108. Yoon J, Si Y, Nolan R, Lee K. Modular decomposition of metabolic reaction networks based on flux analysis and pathway projection. Bioinformatics. 2007;23(18):2433-40.
109. Savinell J, Palsson BO. Network analysis of intermediary metabolism using linear optimization. II. Interpretation of hybridoma cell metabolism. J Theor Biol. 1992;154:455-73.
110. Savinell JM, Palsson BO. Network analysis of intermediary metabolism using linear optimization. I. Development of mathematical formalism. J Theor Biol. 1992;154(4):421-54.
111. Wahl A, Sidorenko Y, Dauner M, Genzel Y, Reichl U. Metabolic flux model for an anchorage-dependent MDCK cell line: characteristic growth phases and minimum substrate consumption flux distribution. Biotechnol Bioeng. 2008;101(1):135-52.
112. Heino J, Tunyan K, Calvetti D, Somersalo E. Bayesian flux balance analysis applied to a skeletal muscle metabolic model. J Theor Biol. 2007;248(1):91-110.
113. Tekir SD, Cakir T, Ulgen KO. Analysis of enzymopathies in the human red blood cells by constraint-based stoichiometric modeling approaches. Comp Biol Chem. 2006;30(5):327-38.
114. Segrè D, Vitkup D, Church GM. Analysis of optimality in natural and perturbed metabolic networks. Proc Natl Acad Sci U S A. 2002;99(23):15112-7.
115. Shlomi T, Berkman O, Ruppin E. Regulatory on/off minimization of metabolic flux changes after genetic perturbations. Proc Natl Acad Sci U S A. 2005;102(21):7695-700.
116. Uygun K, Matthew HWT, Huang Y. Investigation of metabolic objectives in cultured hepatocytes. Biotechnol Bioeng. 2007;97(3):622-37.
117. Nagrath D, Avila-Elchiver M, Berthiaume F, Tilles A, Messac A, Yarmush M. Integrated energy and flux balance based multiobjective framework for large-scale metabolic networks. Ann Biomed Eng. 2007;35(6):863-85.
118. Nagrath D, Avila-Elchiver M, Berthiaume F, Tilles AW, Messac A, Yarmush ML. Soft constraints-based multiobjective framework for flux balance analysis. Metab Eng. 2010;12(5):429-45.
119. Sharma NS, Ierapetritou MG, Yarmush ML. Novel quantitative tools for engineering analysis of hepatocyte cultures in bioartificial liver systems. Biotechnol Bioeng. 2005;92(3):321-35.
120. Llaneras F, Picó J. An interval approach for dealing with flux distributions and elementary modes activity patterns. J Theor Biol. 2007;246(2):290-308.
121. Wiback SJ, Mahadevan R, Palsson BO. Reconstructing metabolic flux vectors from extreme pathways: defining the [alpha]-spectrum. J Theor Biol. 2003;224(3):313-24.
122. Schilling CH, Letscher D, Palsson BO. Theory for the systemic definition of metabolic pathways and their use in interpreting metabolic function from? A pathway-oriented perspective. J Theor Biol. 2000;203(3):229-48.
123. Nookaew I, Meechai A, Thammarongtham C, Laoteng K, Ruanglek V, Cheevadhanarak S, et al. Identification of flux regulation coefficients from elementary flux modes: a systems biology tool for analysis of metabolic networks. Biotechnol Bioeng. 2007;97(6):1535-49.
124. Schwartz JM, Kanehisa M. Quantitative elementary mode analysis of metabolic pathways: the example of yeast glycolysis. BMC Bioinformatics. 2006;7.
125. Schwartz JM, Kanehisa M. A quadratic programming approach for decomposing steady-state metabolic flux distributions onto elementary modes. Bioinformatics. 2005;21:204-5.
126. Zhao QY, Kurata H. Maximum entropy decomposition of flux distribution at steady state to elementary modes. J Biosci Bioeng. 2009;107(1):84-9.
127. Cakir T, Tacer CS, Ulgen KO. Metabolic pathway analysis of enzyme-deficient human red blood cells. Biosystems. 2004;78(1-3):49-67.
128. Nookaew I, Meechai A, Thammarongtham C, Laoteng K, Ruanglek V, Cheevadhanarak S, et al. Network-based analysis of metabolic regulation in the human red blood cell. J Theor Biol. 2003;225(2):185-94.
129. Wiback SJ, Palsson BO. Extreme pathway analysis of human red blood cell metabolism. Biophys J. 2002;83(2):808-18.
130. Stephanopoulos GN, Aristidou AA, Nielsen J. Metabolic engineering principles and methodologies. San Diego, California: Academic Press; 1998.
131. Cascante M, Boros LG, Comin-Anduix B, de Atauri P, Centelles JJ, Lee PWN. Metabolic control analysis in drug discovery and disease. Nat Biotech. 2002;20(3):243-9.
132. Orosz F, Vértessy BG, Hollán S, Horányi M, Ovádi J. Triosephosphate isomerase deficiency: predictions and facts. J Theor Biol. 1996;182(3):437-47.
133. Schuster R, Holzhütter H-G. Use of mathematical models for predicting the metabolic effect of large-scale enzyme activity alterations. Eur J Biochem. 1995;229(2):403-18.
134. Jeneson JAL, Westerhoff HV, Kushmerick MJ. A metabolic control analysis of kinetic controls in ATP free energy metabolism in contracting skeletal muscle. Am J Physiol: Cell Physiol. 2000;279(3):C813-C832.
135. Soboll S, Oh M-H, Brown GC. Control of oxidative phosphorylation, gluconeogenesis, ureagenesis and ATP turnover in isolated perfused rat liver analyzed by top-down metabolic control analysis. Eur J Biochem. 1998;254(1):194-201.
136. Bakker BM, Michels PAM, Opperdoes FR, Westerhoff HV. What controls glycolysis in bloodstream form Trypanosoma brucei? J Biol Chem. 1999;274(21):14551-9.
137. Rossignol R, Letellier T, Malgat M, Rocher C, Mazat JP. Tissue variation in the control of oxidative phosphorylation: implication for mitochondrial diseases. Biochem J. 2000;347 Pt 1:45-53.
138. Comín-Anduix B, Boren J, Martinez S, Moro C, Centelles JJ, Trebukhina R, et al. The effect of thiamine supplementation on tumour proliferation. Eur J Biochem. 2001;268(15):4177-82.
139. Goudar C, Biener R, Boisart C, Heidemann R, Piret J, de Graaf A, et al. Metabolic flux analysis of CHO cells in perfusion culture by metabolite balancing and 2D C-13, H-1 COSY NMR spectroscopy. Metab Eng. 2010;12(2):138-49.
140. Barrett CL, Price ND, Palsson BO. Network-level analysis of metabolic regulation in the human red blood cell using random sampling and singular value decomposition. BMC Bioinformatics. 2006;7.
141. Wiback SJ, Famili I, Greenberg HJ, Palsson BO. Monte Carlo sampling can be used to determine the size and shape of the steady-state flux space. J Theor Biol. 2004;228(4):437-47.
142. Orman MA, Ierapetritou MG, Androulakis IP, Berthiaume F. Metabolic response of perfused livers to various oxygenation conditions. Biotechnology and Bioengineering. 2011;108(12):2947-57.
143. Noguchi Y, Young JD, Aleman JO, Hansen ME, Kelleher JK, Stephanopoulos G. Effect of anaplerotic fluxes and amino acid availability on hepatic lipoapoptosis. J Biol Chem. 2009;284(48):33425-36.
144. Si Y, Shi H, Lee K. Metabolic flux analysis of mitochondrial uncoupling in 3T3-L1 adipocytes. PLoS ONE. 2009;4(9):e7000.
145. Si Y, Shi H, Lee K. Impact of perturbed pyruvate metabolism on adipocyte triglyceride accumulation. Metab Eng. 2009;11(6):382-90.
146. Si Y, Yoon J, Lee K. Flux profile and modularity analysis of time-dependent metabolic changes of de novo adipocyte formation. Am J Physiol: Endocrin Metab. 2007;292(6):E1637-E1646.
147. Vriezen N, van Dijken JP. Fluxes and enzyme activities in central metabolism of myeloma cells grown in chemostat culture. Biotechnol Bioeng. 1998;59(1):28-39.
148. Reed JL, Vo TD, Schilling CH, Palsson BO. An expanded genome-scale model of Escherichia coli K-12 (iJR904 GSM/GPR). Genome Biol. 2003;4(9):R54.
149. Thiele I, Vo TD, Price ND, Palsson BO. Expanded metabolic reconstruction of Helicobacter pylori (iIT341 GSM/GPR): an in silico genome-scale characterization of single-and double-deletion mutants. J Bacteriol. 2005;187(16):5818-30.
150. Lee JM, Gianchandani EP, Eddy JA, Papin JA. Dynamic analysis of integrated signaling, metabolic, and regulatory networks. Plos Comp Biol. 2008;4(5).
151. Ramkrishna D, Kompala DS, Tsao GT. Are microbes optimal strategists? Biotechnol Prog. 1987;3(3):121-6.
152. Edwards JS, Ibarra RU, Palsson BO. In silico predictions of Escherichia coli metabolic capabilities are consistent with experimental data. Nature Biotechnol. 2001;19(2):125-30.
153. Llaneras F, Pico J. A procedure for the estimation over time of metabolic fluxes in scenarios where measurements are uncertain and/or insufficient. BMC Bioinformatics. 2007;8.
154. Zupke C, Stephanopoulos G. Intracellular flux analysis in hybridomas using mass balances and in vitro C-13 NMR. Biotechnol Bioeng. 1995;45(4):292-303.